These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

388 related articles for article (PubMed ID: 11119611)

  • 1. Kaposi's sarcoma-associated herpesvirus LANA2 is a B-cell-specific latent viral protein that inhibits p53.
    Rivas C; Thlick AE; Parravicini C; Moore PS; Chang Y
    J Virol; 2001 Jan; 75(1):429-38. PubMed ID: 11119611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p53 inhibition by the LANA protein of KSHV protects against cell death.
    Friborg J; Kong W; Hottiger MO; Nabel GJ
    Nature; 1999 Dec 23-30; 402(6764):889-94. PubMed ID: 10622254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recruitment of the tumour suppressor protein p73 by Kaposi's Sarcoma Herpesvirus latent nuclear antigen contributes to the survival of primary effusion lymphoma cells.
    Santag S; Jäger W; Karsten CB; Kati S; Pietrek M; Steinemann D; Sarek G; Ojala PM; Schulz TF
    Oncogene; 2013 Aug; 32(32):3676-85. PubMed ID: 22964633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus interacts with human myeloid cell nuclear differentiation antigen induced by interferon alpha.
    Fukushi M; Higuchi M; Oie M; Tetsuka T; Kasolo F; Ichiyama K; Yamamoto N; Katano H; Sata T; Fujii M
    Virus Genes; 2003 Dec; 27(3):237-47. PubMed ID: 14618084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kaposi's sarcoma-associated herpesvirus-encoded latency-associated nuclear antigen induces chromosomal instability through inhibition of p53 function.
    Si H; Robertson ES
    J Virol; 2006 Jan; 80(2):697-709. PubMed ID: 16378973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spindle cell conversion by Kaposi's sarcoma-associated herpesvirus: formation of colonies and plaques with mixed lytic and latent gene expression in infected primary dermal microvascular endothelial cell cultures.
    Ciufo DM; Cannon JS; Poole LJ; Wu FY; Murray P; Ambinder RF; Hayward GS
    J Virol; 2001 Jun; 75(12):5614-26. PubMed ID: 11356969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of the bipartite nuclear localization signal of protein LANA2 from Kaposi's sarcoma-associated herpesvirus.
    Muñoz-Fontela C; Rodríguez E; Nombela C; Arroyo J; Rivas C
    Biochem J; 2003 Sep; 374(Pt 2):545-50. PubMed ID: 12767255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential viral protein expression in Kaposi's sarcoma-associated herpesvirus-infected diseases: Kaposi's sarcoma, primary effusion lymphoma, and multicentric Castleman's disease.
    Parravicini C; Chandran B; Corbellino M; Berti E; Paulli M; Moore PS; Chang Y
    Am J Pathol; 2000 Mar; 156(3):743-9. PubMed ID: 10702388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The KSHV latency-associated nuclear antigen: a multifunctional protein.
    Komatsu T; Ballestas ME; Barbera AJ; Kaye KM
    Front Biosci; 2002 Mar; 7():d726-30. PubMed ID: 11861213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The latency protein LANA2 from Kaposi's sarcoma-associated herpesvirus inhibits apoptosis induced by dsRNA-activated protein kinase but not RNase L activation.
    Esteban M; García MA; Domingo-Gil E; Arroyo J; Nombela C; Rivas C
    J Gen Virol; 2003 Jun; 84(Pt 6):1463-1470. PubMed ID: 12771415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patterns of gene expression and a transactivation function exhibited by the vGCR (ORF74) chemokine receptor protein of Kaposi's sarcoma-associated herpesvirus.
    Chiou CJ; Poole LJ; Kim PS; Ciufo DM; Cannon JS; ap Rhys CM; Alcendor DJ; Zong JC; Ambinder RF; Hayward GS
    J Virol; 2002 Apr; 76(7):3421-39. PubMed ID: 11884567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a nuclear export signal in the KSHV latent protein LANA2 mediating its export from the nucleus.
    Muñoz-Fontela C; Collado M; Rodriguez E; García MA; Alvarez-Barrientos A; Arroyo J; Nombela C; Rivas C
    Exp Cell Res; 2005 Nov; 311(1):96-105. PubMed ID: 16214130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Triptolide decreases expression of latency-associated nuclear antigen 1 and reduces viral titers in Kaposi's sarcoma-associated and herpesvirus-related primary effusion lymphoma cells.
    Long C; Guo W; Zhou H; Wang J; Wang H; Sun X
    Int J Oncol; 2016 Apr; 48(4):1519-30. PubMed ID: 26821279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen 1 mediates episome persistence through cis-acting terminal repeat (TR) sequence and specifically binds TR DNA.
    Ballestas ME; Kaye KM
    J Virol; 2001 Apr; 75(7):3250-8. PubMed ID: 11238851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of cellular and viral gene expression by the latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus.
    Renne R; Barry C; Dittmer D; Compitello N; Brown PO; Ganem D
    J Virol; 2001 Jan; 75(1):458-68. PubMed ID: 11119614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen interacts with multifunctional angiogenin to utilize its antiapoptotic functions.
    Paudel N; Sadagopan S; Chakraborty S; Sarek G; Ojala PM; Chandran B
    J Virol; 2012 Jun; 86(11):5974-91. PubMed ID: 22438557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of paclitaxel resistance by the Kaposi's sarcoma-associated herpesvirus latent protein LANA2.
    Muñoz-Fontela C; Marcos-Villar L; Hernandez F; Gallego P; Rodriguez E; Arroyo J; Gao SJ; Avila J; Rivas C
    J Virol; 2008 Feb; 82(3):1518-25. PubMed ID: 18032494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered patterns of cellular gene expression in dermal microvascular endothelial cells infected with Kaposi's sarcoma-associated herpesvirus.
    Poole LJ; Yu Y; Kim PS; Zheng QZ; Pevsner J; Hayward GS
    J Virol; 2002 Apr; 76(7):3395-420. PubMed ID: 11884566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary B Lymphocytes Infected with Kaposi's Sarcoma-Associated Herpesvirus Can Be Expanded In Vitro and Are Recognized by LANA-Specific CD4+ T Cells.
    Nicol SM; Sabbah S; Brulois KF; Jung JU; Bell AI; Hislop AD
    J Virol; 2016 Apr; 90(8):3849-3859. PubMed ID: 26819313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Covalent modification by SUMO is required for efficient disruption of PML oncogenic domains by Kaposi's sarcoma-associated herpesvirus latent protein LANA2.
    Marcos-Villar L; Campagna M; Lopitz-Otsoa F; Gallego P; González-Santamaría J; González D; Rodriguez MS; Rivas C
    J Gen Virol; 2011 Jan; 92(Pt 1):188-94. PubMed ID: 20881090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.